Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

116.35 +0.10 (+0.09%)
Streaming Delayed Price Updated: 3:06 PM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 845,209
Open 116.28
Bid (Size) 116.27 (2)
Ask (Size) 116.50 (1)
Prev. Close 116.25
Today's Range 113.17 - 117.38
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit
1 Healthcare Stock to Target This Week and 2 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks

Performance

YTD
-18.7%
-18.7%
1 Month
-2.1%
-2.1%
3 Month
-11.6%
-11.6%
6 Month
-30.7%
-30.7%
1 Year
-10.2%
-10.2%

More News

Read More
What Analysts Are Saying About Repligen Stock
Via Benzinga
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Earnings Scheduled For April 29, 2025
Via Benzinga
1 Unprofitable Stock for Long-Term Investors and 2 to Ignore
Via StockStory
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers
Via StockStory
3 of Wall Street’s Favorite Stocks in Hot Water
Via StockStory
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar
Via StockStory
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty
Via StockStory
Topics World Trade
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory
Topics World Trade
Repligen (RGEN) Q1 Earnings: What To Expect
Via StockStory
Topics World Trade
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory
Demystifying Repligen: Insights From 6 Analyst Reviews
Via Benzinga
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
3 Small-Cap Stocks Skating on Thin Ice
Via StockStory
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Via Benzinga

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 116.35
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 07/21/25 03:06 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 6.48B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.